home All News open_in_new Full Article

Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe

Postpartum depression is a leading cause of maternal mortality in Europe1-2, and is one of the most common medical conditions associated with pregnancy3-5; up to 20% of women experience postpartum depressive symptoms6-11 The approval of this new therapeutic approach introduces an oral, 14-day treatment specifically indicated for PPD The EC approval of ZURZUVAE is based […]


today 3 w. ago attach_file Economics

attach_file Politics
attach_file Other
attach_file Other
attach_file Society
attach_file Other
attach_file Events
attach_file Other
attach_file Society
attach_file Other
attach_file Sport
attach_file Society
attach_file Society
attach_file Society
attach_file Other
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Other
attach_file Economics
attach_file Science


ID: 3745494607
Add Watch Country

arrow_drop_down